Jefferies Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-57,500
Closed -$10.6M 1470
2021
Q2
$10.6M Buy
57,500
+44,184
+332% +$8.12M 0.07% 141
2021
Q1
$2.04M Sell
13,316
-72,472
-84% -$11.1M 0.02% 392
2020
Q4
$13.4M Buy
85,788
+79,594
+1,285% +$12.4M 0.11% 70
2020
Q3
$709K Buy
6,194
+4,983
+411% +$570K 0.01% 529
2020
Q2
$136 Sell
1,211
-11,309
-90% -$1.27K ﹤0.01% 665
2020
Q1
$1.09M Sell
12,520
-44,395
-78% -$3.87M 0.01% 446
2019
Q4
$6.16M Buy
56,915
+16,274
+40% +$1.76M 0.05% 185
2019
Q3
$3.98M Buy
40,641
+31,686
+354% +$3.1M 0.03% 274
2019
Q2
$1.17M Buy
8,955
+5,909
+194% +$774K 0.01% 639
2019
Q1
$412K Sell
3,046
-18,298
-86% -$2.47M ﹤0.01% 1012
2018
Q4
$2.08M Buy
21,344
+19,737
+1,228% +$1.92M 0.02% 385
2018
Q3
$223K Sell
1,607
-71,762
-98% -$9.96M ﹤0.01% 1334
2018
Q2
$9.11M Buy
73,369
+65,383
+819% +$8.12M 0.05% 108
2018
Q1
$890K Buy
+7,986
New +$890K ﹤0.01% 709
2017
Q4
Sell
-50,521
Closed -$7.09M 1976
2017
Q3
$7.09M Buy
50,521
+29,527
+141% +$4.14M 0.05% 140
2017
Q2
$2.55M Sell
20,994
-36,439
-63% -$4.43M 0.02% 404
2017
Q1
$6.96M Buy
+57,433
New +$6.96M 0.05% 129
2016
Q3
Sell
-34,441
Closed -$4.02M 1516
2016
Q2
$4.02M Buy
34,441
+29,797
+642% +$3.48M 0.02% 164
2016
Q1
$647K Sell
4,644
-17,631
-79% -$2.46M ﹤0.01% 609
2015
Q4
$4.25M Sell
22,275
-16,549
-43% -$3.16M 0.02% 147
2015
Q3
$6.07M Buy
38,824
+6,787
+21% +$1.06M 0.03% 122
2015
Q2
$5.79M Buy
+32,037
New +$5.79M 0.03% 149
2014
Q4
Sell
-5,116
Closed -$848K 1612
2014
Q3
$848K Sell
5,116
-5,227
-51% -$866K 0.01% 552
2014
Q2
$1.62M Buy
+10,343
New +$1.62M 0.01% 335
2014
Q1
Sell
-771
Closed -$102K 1583
2013
Q4
$102K Sell
771
-2,438
-76% -$323K ﹤0.01% 1084
2013
Q3
$373K Buy
3,209
+2,959
+1,184% +$344K ﹤0.01% 732
2013
Q2
$23K Buy
+250
New +$23K ﹤0.01% 1099